BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19446022)

  • 1. Brain-specific Galphaz interacts with Src tyrosine kinase to regulate Mu-opioid receptor-NMDAR signaling pathway.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; de la Torre-Madrid E; Garzón J
    Cell Signal; 2009 Sep; 21(9):1444-54. PubMed ID: 19446022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Wang JB; Garzón J
    Cell Signal; 2008 Oct; 20(10):1855-64. PubMed ID: 18652891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Sánchez-Blázquez P; Garzón J
    Mol Pain; 2007 Jul; 3():19. PubMed ID: 17634133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGSZ2 binds to the neural nitric oxide synthase PDZ domain to regulate mu-opioid receptor-mediated potentiation of the N-methyl-D-aspartate receptor-calmodulin-dependent protein kinase II pathway.
    Garzón J; Rodríguez-Muñoz M; Vicente-Sánchez A; Bailón C; Martínez-Murillo R; Sánchez-Blázquez P
    Antioxid Redox Signal; 2011 Aug; 15(4):873-87. PubMed ID: 21348811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Garzón J
    PLoS One; 2010 Jun; 5(6):e11278. PubMed ID: 20585660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RGS-Rz and RGS9-2 proteins control mu-opioid receptor desensitisation in CNS: the role of activated Galphaz subunits.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Montero C; Garzón J
    Neuropharmacology; 2005 Jan; 48(1):134-50. PubMed ID: 15617734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance.
    Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
    Curr Drug Abuse Rev; 2012 Sep; 5(3):199-226. PubMed ID: 22920535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery?
    Garzón J; Rodríguez-Muñoz M; Sánchez-Blázquez P
    Curr Drug Abuse Rev; 2008 Jun; 1(2):222-38. PubMed ID: 19630721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling.
    Ajit SK; Ramineni S; Edris W; Hunt RA; Hum WT; Hepler JR; Young KH
    Cell Signal; 2007 Apr; 19(4):723-30. PubMed ID: 17126529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling.
    Georgoussi Z; Leontiadis L; Mazarakou G; Merkouris M; Hyde K; Hamm H
    Cell Signal; 2006 Jun; 18(6):771-82. PubMed ID: 16120478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.
    Leontiadis LJ; Papakonstantinou MP; Georgoussi Z
    Cell Signal; 2009 Jul; 21(7):1218-28. PubMed ID: 19324084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G-protein-coupled receptor-mediated activation of rap GTPases: characterization of a novel Galphai regulated pathway.
    Weissman JT; Ma JN; Essex A; Gao Y; Burstein ES
    Oncogene; 2004 Jan; 23(1):241-9. PubMed ID: 14712229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic morphine acts via a protein kinase Cgamma-G(beta)-adenylyl cyclase complex to augment phosphorylation of G(beta) and G(betagamma) stimulatory adenylyl cyclase signaling.
    Chakrabarti S; Regec A; Gintzler AR
    Brain Res Mol Brain Res; 2005 Jul; 138(1):94-103. PubMed ID: 15908039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells.
    Johnson EA; Oldfield S; Braksator E; Gonzalez-Cuello A; Couch D; Hall KJ; Mundell SJ; Bailey CP; Kelly E; Henderson G
    Mol Pharmacol; 2006 Aug; 70(2):676-85. PubMed ID: 16682505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium/calmodulin-dependent protein kinase II supports morphine antinociceptive tolerance by phosphorylation of glycosylated phosducin-like protein.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Montero C; de la Torre-Madrid E; Garzón J
    Neuropharmacology; 2008 Feb; 54(2):319-30. PubMed ID: 18006024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasticity of adenylyl cyclase-related signaling sequelae after long-term morphine treatment.
    Shy M; Chakrabarti S; Gintzler AR
    Mol Pharmacol; 2008 Mar; 73(3):868-79. PubMed ID: 18045853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kir2.x inward rectifier potassium channels are differentially regulated by adrenergic alpha1A receptors.
    Zitron E; Günth M; Scherer D; Kiesecker C; Kulzer M; Bloehs R; Scholz EP; Thomas D; Weidenhammer C; Kathöfer S; Bauer A; Katus HA; Karle CA
    J Mol Cell Cardiol; 2008 Jan; 44(1):84-94. PubMed ID: 18035370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gbetagamma that interacts with adenylyl cyclase in opioid tolerance originates from a Gs protein.
    Wang HY; Burns LH
    J Neurobiol; 2006 Oct; 66(12):1302-10. PubMed ID: 16967511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Direct involvement of the supraspinal phosphoinositide 3-kinase/phospholipase C gamma 1 pathway in the mu-opioid receptor agonist-induced supraspinal antinociception in the mouse].
    Narita M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Jun; 23(3):121-8. PubMed ID: 12884752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.